Previous study has linked CACNA1B (Cav2.2) to neuropathic pain [43, 44] and CACNA1B (Cav2.2) mutation (R1389H) has been linked to myoclonus-dystonia syndrome, a rare movement disorder [45]. Here, CACNA1B is linked to myoclonus-dystonia syndrome.